ROX zoomed past 85 this morning ... 0.88 Up 0.09 Volume 364,370

0.8305 Up 0.0405 Volume 113,566

Let's hope they surprise to the upside.

Frost is the goose that lays golden eggs.

Cramer mentioned SIRI's $5 price target this morning during his Mad Dash

http://video.cnbc.com/gallery/?play=1&video=3000202429

all right. we got time for the mad dash. i saw greg mafai yesterday, liberty, liberty controls sirius satellite. piper came out and talked about sirius 2.0. this note says they've got hispanic programming is going to take off and used cars sales. this is one of the great retail comebacks, malone. this is going to 5 and this is a stock -- really? going to 5? i think the fundamentals are rapidly improving. it is an overvalued stock on the basis cable. but in terms of the netflix factor, the tesla factor, this is also a well-loved product where people then go buy the stock. i'm saying they may none be so wrong. they believe they can do better in the used car market where people turn it off? do you even look at your bill? don't you pay it automatically? i don't actually subscribe to sirius. ow do you listen to cnbc -- can i suggest you get the football package? i've been here 20 years. it's implanted in my head. i want that root canal. anyway, i think this is going higher and i think people are being rewarded by an excellent management team offering a plethora of programming. and the hispanic entrance, i don't know, sounds like a bright move. he indicated we like the business, we want to stay with it. and him staying with the company is very important.

I bought more this morning at 70¢. I couldn't resist.

Nor was a able to be patient and wait for a dip. I chased it.

I'm out with my 5¢ profit.

I put the money into ROX.

Logitech to Announce Second Quarter Fiscal 2014 Results

NEWARK, Calif. & MORGES, Switzerland--(BUSINESS WIRE)-- Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that it will release quarterly financial results on Wednesday, Oct. 23, 2013 at 10:00 p.m. Eastern Daylight Time and Thursday, Oct. 24, 2013 at 04:00 Central European Summer Time.

There will be a teleconference to discuss these results on Thursday, Oct. 24, 2013 at 8:30 a.m. Eastern Daylight Time and 14:30 Central European Summer Time. A live webcast of the call will be available on the Logitech corporate website at http://ir.logitech.com.



Good things should come from this.

I am waiting for it to slip so I can buy more. It doesn't want to go down enough though.

ROX is less than 12 months from reaching breakeven. It's smooth sailing thereafter.

It may have appeared for a long time that Frost viewed ROX as a hobby, but his track record shows he only wants big winners.

no volume ... no interest.

If it falls back to 10¢ I'll be buying before you.

The fires hurt them but they recovered quickly.

MELA Sciences, Inc. a Leader in the Fight Against Melanoma, Exhibiting MelaFind(R) at the German Skin Cancer Congress

September 25, 2013, 7:05 a.m. ET

MELA Sciences, Inc. a Leader in the Fight Against Melanoma, Exhibiting MelaFind(R) at the German Skin Cancer Congress

IRVINGTON, N.Y., Sept. 25, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind(R), the first and only FDA approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, will be exhibiting MelaFind(R) at the German Skin Cancer Congress (ADO) that will take place in Essen, Germany on September 26-28, 2013. The DeCOG (Dermatologic Cooperative Oncology Group) is affiliated with the German Cancer Society (DKG) and the German Dermatologic Society (DDG).

The Congress will be lead by Prof. Dr. Dirk Schadendorf, ADO Congress Chairman and President, and Director of the Dermatology Department and Clinic at the University of Essen, and will focus on skin cancer prevention. According to the organizers, "the majority of patients are not aware that skin cancer is highly treatable at an early stage, but promising, groundbreaking advances in research and technology have been made and will be presented at the Congress."

MELA Sciences, Inc. will be exhibiting MelaFind(R); a first of its kind, FDA and CE Mark approved, innovative spectral imaging and lesion data analysis system that aids and supports dermatologists' biopsy decisions by non-invasively providing important objective information as deep as 2.5 mm below the skin's surface.

Prof. Dr. Schadendorf and his team at the University of Essen's Dermatology Clinic have been working with the MelaFind(R) system for over twelve months. "MelaFind(R) provides important images and objective data that helps dermatologists better understand the structural disorganization of ambiguous pigmented skin lesions, making it a powerful assist to traditional methods (ABCDEPRU)," commented Dr. Schadendorf. He further noted that, "New technologies such as MelaFind(R) are enriching and complimenting dermatologists' skin cancer examinations by providing useful data about clinically ambiguous pigmented skin lesions that are difficult to differentiate from early-stage melanoma, when the disease is most curable and early detection is most critical to survival."

MelaFind(R) has been recognized by the Cleveland Clinic as a Top 10 Medical Innovation for 2013. Consumers can learn more about the device or locate a dermatologist with MelaFind(R) in their area by visiting www.melafind.com.

About MELA Sciences, Inc.

MELA Sciences is a medical device company focused on the commercialization of its flagship product, MelaFind(R) and its further design and development. MelaFind(R) is a non-invasive tool to provide additional information to dermatologists during melanoma skin examinations. The device uses light from visible to near-infrared wavelengths to evaluate skin lesions up to 2.5 mm beneath the skin. The device provides information on a lesion's level of morphologic disorganization to provide additional objective information that may be used by dermatologists in the biopsy decision-making process. MelaFind(R) has been approved by the US Food and Drug Administration for use in the US. In addition, MelaFind(R) has received CE Mark approval and is approved for use in the European Union.

For more information on MELA Sciences, visit www.melasciences.com.

About Association of Dermatologic Oncology (ADO) / Arbeitsgemeinschaft Dermatologishe Onkologie (ADO)

The DeCOG (Dermatologic Cooperative Oncology Group) is affiliated with the German Cancer Society (DKG) and the German Dermatologic Society (DDG). Founded in 1990, it promotes dermato-oncology to increase the quality of care for patients and to establish standards for skin cancer detection and treatment. This year's Congress will take place in Essen, Germany from September 26--28, 2013, and will be lead by Prof. Dr. Dirk Schadendorf, Director of the dermatology clinic at the University of Essen. http://www.ado-kongress.de/

I wonder what's going on. Volume has been light but the price is right.

It's been a fun 2 days!

$8.5 billion is the biggest settlement case remaining for BAC. It's a linchpin moment.

Win and BAC can start coasting down hill. Lose and a whole new can of worms opens.

The only difference I see in the up or down pop after the ruling is announced is that if BAC loses I think the downward plunge will be twice what the upside pop will be if they were to win.

People have bid up BAC because they think they will win.

If they lose the shock will be widespread and the sell off quite dramatic. No one really knows what it will mean to creditors and the market if Bank of America BK's Countrywide.

I believe BAC will win but I have stopped accumulating.

BAC will POP or DROP by $2 - $4 on the day the AIG settlement verdict is announced.

I've been accumulating since $7.39 and am "banking" on a positive outcome. The day they "write-the-$8.5-billion-dollar-check" will be a red letter day for the company.

This little company keeps chugging up the hill.

SNV will pop on the first hint of more good news.

You will be happy when you listen to this webcast from this morning.


Kinder Morgan Investor Webcast

http://www.kindermorgan.com/investor/presentations/presentations.cfm

Not a high probability for the commoners not to be cancelled if secured creditors have to take a haircut to get Exide out of BK.

These five well known stocks could realistically be ten baggers by 2020

This was the first stock listed of the 5.

(From Market Itelligence Center)


SIRIUS XM Radio (SIRI)
There are two ways of looking at SIRIUS XM Radio; the first is as a once-major media company with a stock that fell in value from over $60 per share to $0.11 per share between the years of 2000 and 2009, as it became clear that Internet distribution was going to cut deeply into, if not completely replace, satellite radio. The second is as a savvy media company that has, by steadily growing its subscriber base, increasing its revenue for ten years in a row, and increasing its profits each year since it became profitable in 2009, managed to increase the price of its stock by a factor of 32.

If you can subtract out the fact the company has too many shares outstanding, the fundamentals start to look quite reasonable. Not only has the company proved its non-obsolescence by surviving for more than ten years in the iPod/smartphone era, but its growth has been quite exceptional. Earlier this month, SIRIUS XM Radio announced its most ambitious plan yet to woo more subscribers by offering a lower-cost subscription model. If that fails, the company can always try its nuclear option—dropping subscription fees altogether in favor of advertising-based revenue.

There are risks here. The long-term viability of SIRIUS XM Radio's business model is still open to question, but the company's entrenched deals with content providers, its large subscriber base, and the sheer tenacity it has shown by clawing its way back from the brink of oblivion make me very confident in its future.

it just keeps on going up.

731,352 ... great volume again (@3:41)

No Form 4 filings at Edgar.

A pretty amazing day for ROX.

The chart shows quit a spike and the volume exceeded all but a handful of days in the past 5 years.

ROX $0.64 Up +0.13 +26.49%

ROX $0.64 Up +0.13 +26.49%

$0.64 Up +0.13 +26.49% ROX

Sweet

I agree with the potential to double revenue over the next few years as new car sales continue to catch-up and the ancillary services and used car reactivations add to the top line.

As share buy-backs continue, the share price will more than double based on predictable growth while the programs and revenues gain traction.

Bought more this morning at 50¢.

Planning to buy more on the way up.

Frost's track record is that he will buy more too. I will buy with him.

Good news about MELA may come any day. Sooner would be better than later, but there is no time table.

We know management is focused on the self inflicted problems. They ousted the guy responsible.

Management says they are working on solutions. We're not going to see incremental moves and applications. When there is something substantial to announce, it will just "come out".

Watch ROX too.

Terrific article. The interview links were good to.

MELA has managed to get a lot of PR interviews aired around the country. It's good to see this one is new and covered in the WSJ.

It seems to have support here. Somehow "Frost Stocks" have it when they need it.

LOGI up 25% since May

LOGI up 25% since May

Funny, I'm looking to buy when it drops under 60 cents, but it does seem to have support right around this point.

Sonny, looking forward to watching your DKAM banter over here.

What turned you on to MELA?

3 insiders/directors bought on the open market at $7.87 on Sept 4th.

I'll be happy to see more insider buying at any price.

The turn-around is well underway.

A slew of new products and terrific product reviews from around the world are propelling excitement. I've bought all I can afford to buy until I see more success in the financials.

I fear cost cutting is so important that the board may have put on hold hiring a new CEO who might be the right person to execute the action plan they know they need to enact.

I will be buying more when it drops below 50¢.